Clinical trial
A Prospective, Observational Study of Patients With Fabry Disease (US Specific)
NCT06906367 is registered in ClinicalTrials.gov with Amicus Therapeutics as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Prospective, Observational Study of Patients With Fabry Disease (US Specific)
- Lead sponsor
- Amicus Therapeutics
- Phase
- Observational
- Overall status
- Recruiting
- Start date
- February 13, 2026
- Completion date
- June 30, 2032
- Enrollment
- 450 (estimated)
- Sites
- 8
Conditions
As the registry lists them; a condition with its own page is linked.